Massachusetts Financial Services’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-63,057	Closed	-$591K	–	872
2023 Q3	$591K	Sell	63,057 -2,417	-4%	-$34.5K	﹤0.01%	797
2023 Q2	$1.61M	Sell	65,474 -1,542	-2%	-$38.7K	﹤0.01%	724
2023 Q1	$1.56M	Sell	67,016 -39,948	-37%	-$1.02M	﹤0.01%	726
2022 Q4	$2.71M	Buy	106,964 +2,257	+2%	+$55.3K	﹤0.01%	700
2022 Q3	$2.02M	Sell	104,707 -958	-0.9%	-$24.4K	﹤0.01%	725
2022 Q2	$2.69M	Buy	105,665 +537	+0.5%	+$12.5K	﹤0.01%	691
2022 Q1	$2.7M	Buy	+105,128	New	+$3.12M	﹤0.01%	721
2021 Q2	–	Sell	-20,152	Closed	-$1.03M	–	942
2021 Q1	$1.03M	Sell	20,152 -33,335	-62%	-$1.8M	﹤0.01%	832
2020 Q4	$1.43M	Buy	53,487 +17,741	+50%	+$577K	﹤0.01%	771
2020 Q3	$1.23M	Buy	+35,746	New	+$1.54M	﹤0.01%	761